Li Sun is a prominent inventor based in Fujian, China. He has made significant contributions to the field of biotechnology, particularly in the development of modified hormones and therapeutic agents. With a total of 4 patents, his work has the potential to impact various medical treatments.

Latest Patents

One of Li Sun's latest patents is titled "Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof." This invention provides a growth hormone with high biological activity modified by double-stranded polyethylene glycol at a single site. The PEGylated growth hormone exhibits higher biological activity and a longer half-life compared to unmodified growth hormone. This composition is particularly useful in treating growth or development disorders such as growth hormone deficiency and Turner syndrome.

Another notable patent is "Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof." This invention relates to interferon (IFN)-α2a modified at a specific Lys residue with a Y-shaped branched polyethylene glycol (PEG) derivative. The preparation method and the use of the modified IFN-α2a in medicines highlight the innovative approach taken by Li Sun in enhancing therapeutic efficacy.

Career Highlights

Li Sun is currently associated with Biosteed Gene Expression Tech. Co., Ltd., where he continues to advance his research and development efforts. His work in the field of biotechnology has garnered attention for its potential applications in medicine.

Collaborations

Li Sun collaborates with notable colleagues, including Weidong Zhou and Qingjiang Xiao, who contribute to his innovative projects and research initiatives.

Conclusion

Li Sun's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatment options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.